Dr. Semerjian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Michigan Medicine
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-647-8902Fax+1 734-712-8111
Summary
- Alice Semerjian, MD is a urologist practicing in Ann Arbor, MI, specializing in urologic oncology. She completed her medical education at the George Washington University School of Medicine and Health Sciences in 2011, and completed a fellowship in Urologic Oncology at Johns Hopkins University in 2018. Dr. Semerjian has worked as a urologist at Michigan Medicine, Trinity Health St Joseph Mercy Hospital. She also served as a Urologic Oncology Fellow at Johns Hopkins Hospital. Dr. Semerjian's experience includes kidney cancer, bladder cancer, upper tract urothelial cancer, prostate cancer and other urologic cancers. She has numerous publications in well-respected journals, mainly focusing on prostate cancer and surgical quality in kidney surgery.
Education & Training
Johns Hopkins UniversityUrologic Oncology, 2016 - 2018
George Washington UniversityResidency, Urology, 2012 - 2016- George Washington University School of MedicineInternship, Transitional Year, 2011 - 2012
- George Washington University School of Medicine and Health SciencesClass of 2011
Certifications & Licensure
MI State Medical License 2018 - 2025
MD State Medical License 2016 - 2019
VA State Medical License 2011 - 2015
DC State Medical License 2011 - 2012
American Board of Urology Urology
Publications & Presentations
PubMed
- Robotic partial nephrectomy: Techniques for complex tumors.Renee Cole, Alice Semerjian
Urologic Oncology. 2025-02-24 - Percutaneous microwave ablation of cT1b renal cell carcinoma: safety and oncologic efficacy in a large, single-center elderly and comorbid cohort.Shane A Wells, Daniel Shapiro, Tudor Borza, Glenn Allen, J Louis Hinshaw
Abdominal Radiology. 2025-02-06 - The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses.Michael Wang, Aaron Wilke, Samuel Goorman, Andrew McElroy, Jack Vercnocke
Urologic Oncology. 2024-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
